The International Center for Public Health was designed by the Princeton-based architectural firm CUH2A for advanced studies in microbiology and infectious diseases in extensive consultation with PHRI faculty. The general biosafety level 2 (BSL2) laboratories are ideal for microbiological and molecular biological investigations and the open landscape design, in which laboratories from one to the other without barrier walls, promotes a sense of community, collegiality and collaboration.
The study of infectious diseases requires specialized facilities to perform research safely and efficiently with highly transmissible pathogenic agents. In many cases, specialized containment laboratories are required. The PHRI operation at the International Center for Public Health houses some of the most advanced laboratories for the study of biological agents under biosafety level 3 (BSL3) conditions, including one of the largest BSL3 animal research (vivarium) programs in the Northeast USA.
The new Rutgers Regional Biocontainment Laboratory (Rutgers RBL) is a self-contained 40,000 sq ft facility that serves as one of thirteen national centers designated by the National Institutes of Health (NIH) for research on biosafety level 3 (BSL3) infectious agents. Adjoining the BSL3 vivarium and BSL3 laboratories at the International Center for Public Health (ICPH), the total BSL3 operation at the ICPH comprises more than 13,000 sq ft of vivarium and laboratory spaces dedicated to BLS3 pathogens. Under the direction of Dr. David S. Perlin, Executive Director of the Public Health Research Institute (PHRI), the Rutgers RBL operation advances the national biomedical research agenda by addressing a basic understanding of pathogen biology and promoting the development of new vaccines, therapeutics and diagnostics against existing and emerging infectious agents.
For more information about Rutgers Regional Biocontainment Laboratory, please visit njms.rutgers.edu/research/rbl/